CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 140 enrolled
Drug / intervention
Methylprednisolone +1 moredrug
Likely dose
Methylprednisolone 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03311425
NCT03311425Phase 3Completed

The Effects of Intraoperative Local and Systemic Corticosteroid Administration on Postoperative Dysphagia After Anterior Cervical Fusion

Rush University Medical Center·interventional·Posted Oct 17, 2017·Updated Nov 20, 2020

In Brief

A Phase 3 clinical trial evaluating Methylprednisolone and Dexamethasone for Dysphagia. Completed, enrolled 140 participants.

Detailed Summary

The purpose of this study is to determine if the incidence and duration of postoperative dysphagia are improved in the participants receiving a local injection of methylprednisolone with systemic dexamethasone when compared to those receiving the usual systemic dexamethasone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDysphagia
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 17, 2017
Enrollment StartAug 1, 2014
Primary CompletionJun 27, 2017
Study CompletionJul 20, 2019
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 8.7 years ago

Interventions

Methylprednisolonedrug

Application of 40mg Depomedrol (methylprednisolone acetate) suspension into the retropharyngeal space prior to incision closure

Dexamethasonedrug

Administration of 10mg Dexamethasone IV intraoperatively